Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro

Biochem Mol Biol Int. 1995 Aug;36(6):1127-33.

Abstract

Anandamide (AnNH, N-arachidonoyl-ethanolamine) has been recently proposed as the endogenous ligand for mammalian brain cannabinoid receptor. Non-cannabinoid receptor-mediated, intracellular actions have been also found for this novel mediator. Here we present evidence for the modulation by anandamide of rat brain protein kinase C (PKC) activity in vitro. The ethanolamide of arachidonic acid (AA) was more active than the free acid in increasing phosphatidylserine (PS)-induced PKC activation (EC50 = 40 microM), but inhibited dioleylglycerol-induced potentiation of both Ca(2+)- and Ca2+/PS-induced PKC activation (IC50 = 8 microM and 30 microM, respectively). A dual modulatory action of anandamide on PKC, exerted by binding to the diacylglycerol regulatory site, is hypothesized in rat brain.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / pharmacology
  • Arachidonic Acids / pharmacology*
  • Binding Sites
  • Brain / enzymology*
  • Calcium / pharmacology
  • Cannabinoids / pharmacology
  • Endocannabinoids
  • Enzyme Activation
  • Kinetics
  • Phosphatidylserines / pharmacology
  • Polyunsaturated Alkamides
  • Protein Kinase C / metabolism*
  • Rats

Substances

  • Arachidonic Acids
  • Cannabinoids
  • Endocannabinoids
  • Phosphatidylserines
  • Polyunsaturated Alkamides
  • Arachidonic Acid
  • Protein Kinase C
  • Calcium
  • anandamide